Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
about
Serum and Glucocorticoid Regulated Kinase 1 in Sodium HomeostasisSGK1: The Dark Side of PI3K Signaling.Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells.Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma.Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus.Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth.Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell linesAngiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1.Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxiaLnc-SGK1 induced by Helicobacter pylori infection and highsalt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signalingSerum- and glucocorticoid-induced protein kinase 1 (SGK1) is regulated by store-operated Ca2+ entry and mediates cytoprotection against necrotic cell deathFibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation.Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.RNA interference for multiple myeloma therapy: targeting signal transduction pathways.Ras-ling with new therapeutic targets for metastasis.Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma.SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.Next-Generation Sequencing.Overproduction of Sch9 leads to its aggregation and cell elongation in Saccharomyces cerevisiae.Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.
P2860
Q26741611-5883B540-4C0B-4935-BD46-261CF2D2C1ECQ30399129-8288A2B1-2140-44BE-A0E2-999506F6C2B9Q33863571-768E324E-1FAE-4B19-9005-ECB83D0B7A45Q34104052-65028022-B19C-45D6-AEFD-8C3ECC5B9DC1Q34258911-7E9F394B-6DAF-4134-8785-E36A60FFE29BQ34532672-3C5F04DE-1913-4ECB-AD31-91F426063B6CQ34566043-E2826808-1C63-48DA-9746-DC34D11843C9Q35594600-4ABECB3B-B1E8-4B03-A260-8EFC92B997ABQ35613280-B3E8A6BC-8083-44F3-95DA-7C31A6A904FBQ36631392-BB2619C4-D12F-4FD1-BF73-750426E7DA78Q36805679-C4AF1BBE-C368-4496-8A89-41B38765C567Q36955193-2125A499-C433-4560-B334-65A9D35BC99DQ37190366-2CF87041-AC38-4B59-B9BF-C566532BBC2DQ37289311-A8DC5E35-3288-4B3E-A743-C93058C73DF9Q37510049-11A375EB-BF92-49A4-AA0C-82F84096D5F2Q37727820-27A7B614-2655-49BF-A707-8B356A7B814EQ38090700-D216A21C-4040-41FA-926A-3F446066F881Q38177872-77C54422-841E-4F53-8B58-07DB66E5901CQ38550480-EFEB1E8C-9A9A-47C9-886B-991E4374AFC6Q38805139-87002C15-64E3-4411-A46F-4C0AB4D7E396Q38812284-9A3390B3-77F9-43AF-989B-6BE0A708D0E8Q45731755-9BBCD53F-19BB-4DB7-8741-5DEC3E20E9D2Q51032285-837B4DB7-1BB1-4442-92A6-C8CA9C732AC9Q53705532-747C35C1-E3FB-4F89-969D-7C017C4337D3Q54531699-02D13FCB-5D00-4887-B5AD-256664F2490A
P2860
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum/glucocorticoid-regulated ...... s the growth of myeloma cells.
@en
Serum/glucocorticoid-regulated kinase 1
@nl
type
label
Serum/glucocorticoid-regulated ...... s the growth of myeloma cells.
@en
Serum/glucocorticoid-regulated kinase 1
@nl
prefLabel
Serum/glucocorticoid-regulated ...... s the growth of myeloma cells.
@en
Serum/glucocorticoid-regulated kinase 1
@nl
P2093
P2860
P50
P356
P1433
P1476
Serum/glucocorticoid-regulated ...... ts the growth of myeloma cells
@en
P2093
J D Shaughnessy
M Chatterjee
R C Bargou
P2860
P2888
P304
P356
10.1038/ONC.2011.79
P407
P577
2011-04-11T00:00:00Z